Form D — Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
0002138549-26-000001 · filed 2026-07-08
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1
- Total offering
- $1,000,000
- Total sold
- $597,000
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
- CIK
- 2138549
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 107 KILMAYNE DRIVE
CARY, NC 27511 - Phone
- 9193356001
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Michael Harlow · DirectorClayton, NC Find on LinkedIn ↗
-
Robert Earl Ross · DirectorCary, NC Find on LinkedIn ↗
-
John Powell Leachman · DirectorGainesville, GA Find on LinkedIn ↗
View original on SEC EDGAR.